Will cilostazol improve care for patients with intermittent claudication?

被引：0
|
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 1999年 / 14卷 / 1期
关键词：
Human Immunodeficiency Virus Type; Clopidogrel; Peripheral Arterial Disease; Pentoxifylline; Cilostazol;
D O I：
10.2165/00042310-199914010-00001
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：4
相关论文
共 50 条
  • [11] The use of cilostazol in intermittent claudication in patients with peripheral arterial disease
    Wierzchowski, Pawel
    Migdalski, Arkadiusz
    Jawien, Arkadiusz
    ACTA ANGIOLOGICA, 2014, 20 (03): : 101 - 105
  • [12] The role of cilostazol (Pletal™) in the management of intermittent claudication
    Bradbury, AW
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (05) : 405 - 409
  • [13] Cilostazol (pletal) - New treatment for intermittent claudication
    不详
    AMERICAN JOURNAL OF NURSING, 1999, 99 (06) : 24NN - 24NN
  • [14] Safety and efficacy of cilostazol in the management of intermittent claudication
    Chi, Yung-Wei
    Lavie, Carl J.
    Milani, Richard V.
    White, Christopher J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1197 - 1203
  • [15] A comparison of cilostazol and pentoxifylline for treating intermittent claudication
    Dawson, DL
    Cutler, BS
    Hiatt, WR
    Hobson, RW
    Martin, JD
    Bortey, EB
    Forbes, WP
    Strandness, DE
    AMERICAN JOURNAL OF MEDICINE, 2000, 109 (07): : 523 - 530
  • [16] The US experience with cilostazol in treating intermittent claudication
    Hiatt, William R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (04) : 21 - 31
  • [17] Effect of cilostazol on patients with intermittent claudication: role of endothelial progenitor cells
    Tejerina, Teresa
    Ramajo, Marta
    Navarro-Dorado, Jorge
    Medina, Ursula
    Rydings, Manuel H.
    Perera, Miriam
    Puras, Enrique
    Serrano-Hernando, Francisco J.
    Redondo, Santiago
    FASEB JOURNAL, 2013, 27
  • [18] Cilostazol: a novel treatment option in intermittent claudication
    Cariski, AT
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, : 11 - 18
  • [19] Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication
    Wang, T
    Elam, MB
    Forbes, WP
    Zhong, JH
    Nakajima, K
    ATHEROSCLEROSIS, 2003, 171 (02) : 337 - 342
  • [20] EFFECT OF CILOSTAZOL ON ENDOTHELIAL PROGENITOR CELL NUMBER OF PATIENTS WITH INTERMITTENT CLAUDICATION
    Tejerina, T.
    Ramajo, M.
    Navarro-Dorado, J.
    Medina, U.
    Rydings, M. H.
    Perera, M.
    Puras, E.
    Serrano-Hernando, F. J.
    Redondo, S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 13 - 13
12345